These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28245518)

  • 21. Role of senataxin in DNA damage and telomeric stability.
    De Amicis A; Piane M; Ferrari F; Fanciulli M; Delia D; Chessa L
    DNA Repair (Amst); 2011 Feb; 10(2):199-209. PubMed ID: 21112256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Pathogenicity of SETX I1942T Variant in Ataxia with Oculomotor Apraxia Type 2 Through Segregation Analysis.
    Ros-Arlanzón P; Serrano-Serrano B; Aledo-Sala C; Guevara-Dalrymple N; Martí-Martínez S
    Mov Disord Clin Pract; 2024 Aug; 11(8):1041-1043. PubMed ID: 38817201
    [No Abstract]   [Full Text] [Related]  

  • 23. "Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).
    Schöls L; Arning L; Schüle R; Epplen JT; Timmann D
    J Neurol; 2008 Apr; 255(4):495-501. PubMed ID: 18350359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein interaction analysis of senataxin and the ALS4 L389S mutant yields insights into senataxin post-translational modification and uncovers mutant-specific binding with a brain cytoplasmic RNA-encoded peptide.
    Bennett CL; Chen Y; Vignali M; Lo RS; Mason AG; Unal A; Huq Saifee NP; Fields S; La Spada AR
    PLoS One; 2013; 8(11):e78837. PubMed ID: 24244371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
    Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
    Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin.
    Airoldi G; Guidarelli A; Cantoni O; Panzeri C; Vantaggiato C; Bonato S; Grazia D'Angelo M; Falcone S; De Palma C; Tonelli A; Crimella C; Bondioni S; Bresolin N; Clementi E; Bassi MT
    Neurogenetics; 2010 Feb; 11(1):91-100. PubMed ID: 19593598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease.
    Chen YZ; Hashemi SH; Anderson SK; Huang Y; Moreira MC; Lynch DR; Glass IA; Chance PF; Bennett CL
    Neurobiol Dis; 2006 Jul; 23(1):97-108. PubMed ID: 16644229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
    Nakamura K; Yoshida K; Makishita H; Kitamura E; Hashimoto S; Ikeda S
    J Hum Genet; 2009 Dec; 54(12):746-8. PubMed ID: 19893583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation.
    Suraweera A; Lim Y; Woods R; Birrell GW; Nasim T; Becherel OJ; Lavin MF
    Hum Mol Genet; 2009 Sep; 18(18):3384-96. PubMed ID: 19515850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sen1, the homolog of human Senataxin, is critical for cell survival through regulation of redox homeostasis, mitochondrial function, and the TOR pathway in Saccharomyces cerevisiae.
    Sariki SK; Sahu PK; Golla U; Singh V; Azad GK; Tomar RS
    FEBS J; 2016 Nov; 283(22):4056-4083. PubMed ID: 27718307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations.
    Cohen S; Puget N; Lin YL; Clouaire T; Aguirrebengoa M; Rocher V; Pasero P; Canitrot Y; Legube G
    Nat Commun; 2018 Feb; 9(1):533. PubMed ID: 29416069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germ cell arrest associated with aSETX mutation in ataxia oculomotor apraxia type 2.
    Catford SR; O'Bryan MK; McLachlan RI; Delatycki MB; Rombauts L
    Reprod Biomed Online; 2019 Jun; 38(6):961-965. PubMed ID: 30642639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families.
    Hammer MB; El Euch-Fayache G; Nehdi H; Saidi D; Nasri A; Nabli F; Bouhlal Y; Maamouri-Hicheri W; Hentati F; Amouri R
    Diagn Mol Pathol; 2012 Dec; 21(4):241-5. PubMed ID: 23111195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing.
    Lu C; Zheng YC; Dong Y; Li HF
    BMC Neurol; 2016 Sep; 16(1):179. PubMed ID: 27644330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
    Anheim M; Monga B; Fleury M; Charles P; Barbot C; Salih M; Delaunoy JP; Fritsch M; Arning L; Synofzik M; Schöls L; Sequeiros J; Goizet C; Marelli C; Le Ber I; Koht J; Gazulla J; De Bleecker J; Mukhtar M; Drouot N; Ali-Pacha L; Benhassine T; Chbicheb M; M'Zahem A; Hamri A; Chabrol B; Pouget J; Murphy R; Watanabe M; Coutinho P; Tazir M; Durr A; Brice A; Tranchant C; Koenig M
    Brain; 2009 Oct; 132(Pt 10):2688-98. PubMed ID: 19696032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SETX sumoylation: A link between DNA damage and RNA surveillance disrupted in AOA2.
    Richard P; Manley JL
    Rare Dis; 2014; 2():e27744. PubMed ID: 25054092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unwinding the role of senataxin in neurodegeneration.
    Bennett CL; La Spada AR
    Discov Med; 2015 Feb; 19(103):127-36. PubMed ID: 25725227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome.
    Bassuk AG; Chen YZ; Batish SD; Nagan N; Opal P; Chance PF; Bennett CL
    Neurogenetics; 2007 Jan; 8(1):45-9. PubMed ID: 17096168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Senataxin modulates neurite growth through fibroblast growth factor 8 signalling.
    Vantaggiato C; Bondioni S; Airoldi G; Bozzato A; Borsani G; Rugarli EI; Bresolin N; Clementi E; Bassi MT
    Brain; 2011 Jun; 134(Pt 6):1808-28. PubMed ID: 21576111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of ELAV gene-specific regulation.
    Soller M; Li M; Haussmann IU
    Biochem Soc Trans; 2010 Aug; 38(4):1122-4. PubMed ID: 20659015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.